🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Transition From Donor Milk: a Feasibility Study

RecruitingNAAges 28 Days - anyAllAugusta University
NCT06514014 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Preterm and very low birth weight (VLBW, \< 1,500g) infants who receive donor human milk (DHM) often experience slow postnatal growth and no clinical data is available to guide the duration of DHM for preterm infants. The investigators hypothesize that transitioning from DHM to preterm infant formula after the first month of life is both safe and conveys improved weight and length gains and fat free mass accumulation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Greater than 1,250 grams 2. At least 28 days of life 3. Diet consisting of donor human milk with/without mother's own milk Exclusion Criteria: 1. Birth weight below the 5th percentile 2. History of necrotizing enterocolitis, spontaneous intestinal perforation, or other gastrointestinal disorder 3. Congenital anomalies 4. Care team discretion
💊

What it tests

  • Preterm Infant Formula
📍

Where

1 site
Wellstar-MCG
Augusta, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy